Company / Inventory per Share
ALNYLAM PHARMACEUTICALS, INC. Inventory per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.64
FY2025
5-year range
$0.62 / $1.07
FY2021-FY2025
Trend
+2.5%
vs FY2024
Sector context
#48 of 105
Health Care
What the data says
At $0.64, ALNYLAM PHARMACEUTICALS, INC.'s inventory per share ranks #48 of 105 in the Health Care sector. Inventory per Share returned to growth in FY2025 after 2 years of decline, reaching $0.64.
Based on SEC 10-K filings.
0.64 in FY2025 with a 5-year CAGR of -0.9%.
Declined from $0.72 to $0.64 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- -15.8%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
#48 of 105 in Health CareTop 46% of 105This company $0.64 Sector average $30.82
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2025, inventory per share increased 2.5% year-over-year.
- Ranks #48 out of 105 companies in the Health Care sector.
- Peak inventory per share was recorded in FY2022.
- Lowest inventory per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.37 (distress zone, below 1.8 threshold)
- Negative profit margin: -12.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.64 | +2.5% |
| FY2024 | $0.62 | -13.2% |
| FY2023 | $0.72 | -33.0% |
| FY2022 | $1.07 | +44.7% |
| FY2021 | $0.74 | +10.7% |
| FY2020 | $0.67 | +20.4% |
| FY2019 | $0.56 | +130.6% |
| FY2018 | $0.24 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026